TY  - CONF

T1  - EXPLORATORY ECONOMIC EVALUATION OF ADJUVANT TREATMENT OF NON-SMALL-CELL LUNG CANCER (NSCLC) WITH BEVACIZUMAB IN ADDITION TO A CISPLATIN-BASED TREATMENT REGIMEN IN THE UNITED KINGDOM

JO  - VALUE HEALTH

PY  - 2008/11/01

AU  - Gyldmark M

AU  - Gatzemeier U

AU  - Nicolson M

AU  - Latimer N

AU  - Walzer S

ED  - 

VL  - 11

IS  - 6

SP  - A357

EP  - A357

Y2  - 2024/12/22

ER  -